Skip to main navigation
Skip to search
Skip to main content
Tel Aviv University Home
Update Request & User Guide (TAU staff only)
Home
Experts
Research units
Research output
Datasets
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
IGF-1 and BRCA1 signalling pathways in familial cancer
Haim Werner
*
, Ilan Bruchim
*
Corresponding author for this work
Human Molecular Genetics Biochemistry
Meir Hospital Sapir Medical Center
Research output
:
Contribution to journal
›
Review article
›
peer-review
73
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'IGF-1 and BRCA1 signalling pathways in familial cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Growth Factors
100%
Insulin-like
100%
Signaling Pathway
100%
Breast Cancer Susceptibility Gene 1 (BRCA1)
100%
Familial Cancer
100%
Environmental Factors
28%
Genetic Factors
28%
Factor System
28%
Polymorphism
14%
Complex Interactions
14%
Tumor
14%
BRCA mutation
14%
Cell Proliferation
14%
Cancer Risk
14%
Cancer Therapy
14%
Cell Survival
14%
Molecular Targets
14%
Ovarian Cancer
14%
BRCA2
14%
Chain of Events
14%
Clinical Evidence
14%
Breast Cancer Recurrence
14%
System Components
14%
Cellular Survival
14%
Epidemiological Evidence
14%
Growth Factor Signaling Pathways
14%
Molecular Chain
14%
Predictive Biomarker
14%
Predictive Approach
14%
Molecular Oncology
14%
Ambient Concentration
14%
Medicine and Dentistry
BRCA1
100%
Signal Transduction
100%
Somatomedin C
100%
Somatomedin
100%
Familial Cancer
100%
Malignant Neoplasm
50%
Cell Survival
50%
Environmental Factor
50%
Biological Marker
25%
Mediator
25%
BRCA Mutation
25%
Neoplasm
25%
Cell Proliferation
25%
Cancer Therapy
25%
Breast Cancer
25%
Ovarian Cancer
25%
BRCA2
25%
Molecular Oncology
25%
Biochemistry, Genetics and Molecular Biology
Signal Transduction
100%
Insulin-Like Growth Factor 1
100%
BRCA1
100%
Insulin-Like Growth Factor
100%
Genetics
50%
Cell Survival
50%
Cell Proliferation
25%
Mediator
25%
BRCA2
25%